A new Gaussian process framework learns sparse, ordered dependency graphs from irregular electronic health records while ...

Digitalization at the University Medical Center Mainz (UM), as part of its future programme UM.Digital, has reached another ...

Timothy A. Yap, MBBS, Ph.D., FRCP, of The University of Texas MD Anderson Cancer Center to present results from the dose escalation phase of the ...

ProQR Therapeutics N.V. announced upcoming presentations highlighting clinical and preclinical progress with AX-0810 and ...

AI-driven protocols, adaptive trials, synthetic control arms and Asia-Pacific expansion can cut costs, reduce screening failures and accelerate oncology studies.Dublin, Oct. (GLOBE NEWSWIRE) -- ...

United Therapeutics Corporation (NASDAQ:UTHR) has received clearance from the U.S. Food and Drug Administration (FDA) to begin clinical testing of Treprostinil-Iloprost SMI, an investigational inhaled ...

Parexel’s Stacy Hurt draws on her experience with chemotherapy and as a caregiver to spot patient burdens that AI-assisted ...

ProQR to present its ADAR-mediated RNA editing approach and progress toward next-generation editing oligonucleotides at TIDES Europe plenary ...

When the Michael J. Fox Foundation for Parkinson’s Research launched a major study in 2010, the objective was to help ...

Drug development is a stepwise process, with each clinical phase answering a different question about a treatment's safety ...

Vera Health raises $28.5M in Series A funding led by Threshold Ventures to scale its evidence-graded clinical AI search ...

"Dosing the first patient in the Corventis clinical trial is a milestone for Atrium and, more importantly, for the PRKAG2 ...